| Patents for C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723) |
|---|
| 09/04/2003 | US20030166004 Comprises synthetic or genetically engineered peptide or polypeptide which comprises endothelial cell binding peptides (ECBP) for inhibit angiogenesis and related diseases such as cancer, arthritis and vision defects |
| 09/02/2003 | US6613322 Administering enzyme inhibitors |
| 08/28/2003 | WO2003071268A2 Method for discovering pharmacologically active substances |
| 08/28/2003 | US20030162709 Methods of generating multispecific, multivalent agents from VH and VL domains |
| 08/28/2003 | CA2487395A1 Method for discovering pharmacologically active substances |
| 08/21/2003 | WO2003059385A3 Hiv vaccine and method of use |
| 08/13/2003 | CN1435430A Method for extracting prolamine from corn |
| 08/12/2003 | US6605115 Method and composition for inhibiting cardiovascular cell proliferation |
| 08/07/2003 | WO2003064452A2 Method for the preparation of highly branched polypeptides |
| 08/07/2003 | WO2003063888A1 Antiviral compositions and methods for identification and use |
| 08/07/2003 | US20030148926 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
| 08/07/2003 | US20030148465 Comprises membrane protein for diagnosis and treatment of atherosclerosis, viral and inflammatory diseases |
| 08/05/2003 | US6602509 Compound and method for the prevention and/or the treatment of allergy |
| 07/31/2003 | WO2003062468A2 Method for binding site identification using a multi-scale approach |
| 07/31/2003 | WO2003031571A3 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 07/31/2003 | US20030143661 Enantioselective oligomerization of alpha-hydroxy carboxylic acids and alpha-amino acids |
| 07/31/2003 | US20030143247 For therapy of infections with hepatitis or picornaviruses |
| 07/29/2003 | US6599728 Tankyrase II interacts with telomere-associated proteins, thereby affecting telomerase activity and potentially telomere length |
| 07/24/2003 | WO2003059385A2 Hiv vaccine and method of use |
| 07/24/2003 | WO2003059252A2 Use of a novel cell surface protease from group b streptococcus |
| 07/24/2003 | CA2472579A1 Hiv vaccine and method of use |
| 07/24/2003 | CA2470421A1 Use of a novel cell surface protease from group b streptococcus |
| 07/23/2003 | EP1328552A1 Crosslinked amide derivatives of hyaluronic acid and manufacturing method thereof |
| 07/17/2003 | WO2003057829A2 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 07/17/2003 | WO2002083928A3 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer |
| 07/17/2003 | CA2471868A1 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 07/15/2003 | US6593139 Initiation of full mammalian oocyte activation by multiple sperm components |
| 07/10/2003 | WO2003056299A2 Labeling reagent and methods of use |
| 07/10/2003 | WO2003055901A1 Novel peptide sy |
| 07/10/2003 | US20030129626 Methods, kits and compositions pertaining to the suppression of detectable probe binding to randomly distributed repeat sequences in genomic nucleic acid |
| 07/10/2003 | US20030129207 Obtaining a biological sample from the patient, contacting the sample with a binding agent that binds to a polypeptide, detecting amount of bounded polypeptide, comparing it to a predetermined cut-off value to determine presence of cancer |
| 07/08/2003 | US6590071 Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use |
| 07/03/2003 | WO2002088667A3 ENANTIOSELECTIVE OLIGOMERIZATION OF α-HYDROXY CARBOXYLIC ACIDS AND α-AMINO ACIDS |
| 07/02/2003 | CN1427839A Charged compounds comprising nucleic acid binding moiety and uses therefor |
| 06/26/2003 | US20030119068 Binding; generating libraries using computer; translation, amplification |
| 06/19/2003 | US20030113454 Treatment with a disulphide bridge-cleaving agent to yield unfolded hydrophobin; prevention of the formation of disulphide bridges |
| 06/19/2003 | US20030113333 A kit containing a binding protein and a carrier molecule, binds with a hapten moiety and binds with a target antigen; monoclonal antibodies and engineered antibodies |
| 06/18/2003 | CN1425015A Chlorophyll and bacteriochlorophyll esters, and their preparation |
| 06/12/2003 | WO2003048390A1 A process for the preparation of a non-toxic anthrax vaccine |
| 06/12/2003 | CA2469671A1 A process for the preparation of a non-toxic anthrax vaccine |
| 06/10/2003 | US6576417 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 06/05/2003 | WO2003046201A2 Detection and identification of enteric bacteria |
| 06/05/2003 | CA2812024A1 Methods for ligand discovery |
| 06/05/2003 | CA2466615A1 Detection and identification of enteric bacteria |
| 05/27/2003 | US6569685 Protein fingerprint system and related methods |
| 05/22/2003 | WO2003042249A2 Peptide purification by means of metal ion affinity chromatography |
| 05/20/2003 | US6566509 Compound for use as bactericide |
| 05/14/2003 | EP1309622A2 Lat peptides and their use in assays for identifying immunosuppressants |
| 05/13/2003 | CA2105979C Monoclonal antibody against lps core |
| 05/08/2003 | WO2003037915A1 Biocompatible polymers including peptide spacer |
| 05/08/2003 | WO2003037172A2 Endothelial-cell binding peptides for diagnosis and therapy |
| 05/08/2003 | US20030087379 Measurement of dimerization of viral polymerase; obtain sample containing viral dimerized proteins, incubate with binding agent, determine the amount of complex formed |
| 05/08/2003 | US20030087306 Methods for identifying novel multimeric agents that modulate receptors |
| 05/07/2003 | CN1415627A Reverse osmosis selective method for purifying bioactive peptide RO in enzymolysis liquid of pearl and its equipment |
| 05/02/2003 | EP0968283B1 Generation of diversity in combinatorial libraries |
| 04/29/2003 | US6555693 Compounds that affect the expression of genes essential for the proliferation of the pathogen; promoters or gene expression inhibition; binding to double-stranded DNA; fungicides; bactericides; viricides |
| 04/29/2003 | US6555112 Peptides derived from the lymphadenopathy-associated virus (LAV) envelope coding region |
| 04/24/2003 | WO2003033653A2 Affinity enhancement agents |
| 04/23/2003 | EP1304116A1 New class of bioactive glycoprotein |
| 04/23/2003 | EP1303537A2 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 04/17/2003 | WO2003031571A2 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 04/16/2003 | EP1302540A2 Generation of diversity in combinatorial libraries |
| 04/16/2003 | EP1301604A2 Substrates and assays for beta-secretase activity |
| 04/16/2003 | CN1410437A Method of producing silk peptide, silk amino acid by acid hydrolysis of natural silk |
| 04/03/2003 | WO2003027328A2 Methods, kits and compositions pertaining to the suppression of detectable probe binding to randomly distributed repeat sequences in genomic nucleic acid |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 03/20/2003 | WO2003022126A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 03/19/2003 | EP1292606A2 Positively-charged peptide nucleic acid analogs with improved properties |
| 03/19/2003 | CN1403473A Production process of flax protein powder |
| 03/13/2003 | US20030049685 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 03/12/2003 | EP1291356A2 Process for rapid solution synthesis of petides |
| 03/12/2003 | EP1289974A1 Catalyst comprising soluble polymer and polyamino acid |
| 03/12/2003 | EP0922226B1 Process for determining the status of an organism by peptide measurement |
| 03/06/2003 | US20030044845 Novel therapeutic agents for membrane transporters |
| 02/27/2003 | WO2003016915A1 Tumor specific oligosaccharide sequences and use thereof |
| 02/26/2003 | CN1398876A Fast peptide-synthesizing process in solution |
| 02/20/2003 | WO2003014388A2 Method and nucleic acids for the analysis of colon cancer |
| 02/20/2003 | CA2455161A1 Method and nucleic acids for the analysis of colon cancer |
| 02/18/2003 | US6521744 Binding or complexing oligomers through hydrogen bondin, van der Waals interaction, pi stacking or condensation |
| 02/13/2003 | WO2003012127A2 Assay for identifying inhibitors of hiv rt dimerization |
| 02/13/2003 | US20030032769 Second mammalian tankyrase |
| 02/06/2003 | US20030026796 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase |
| 02/05/2003 | EP1281162A1 The use of proteinaceous molecules in methods for molecular computing |
| 01/30/2003 | US20030022236 Generation of preferental protein libraries; obtain nucleotide sequences, translate in vitro, recover protein product |
| 01/28/2003 | US6511666 Purified antigenic complex comproised of multimeric protein complexes of arginine- and lysine-specific thiol endopepti-dases containing adhesion domains; raising antibody response against porphyromonas gingivalis |
| 01/23/2003 | US20030018164 Automatic biosynthesis cycles |
| 01/23/2003 | US20030017991 Substrates and assays for beta-secretase activity |
| 01/23/2003 | US20030017564 Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiogenesis |
| 01/22/2003 | CN1099425C 新的肽衍生物 New peptide derivatives |
| 01/21/2003 | US6509446 Recombinant genetic information (DNA or RNA), consisting a Chicken Anemia Virus (CAV)-specific nucleotide sequence, useful for diagonestics, vaccination or protein production |
| 01/16/2003 | WO2003004569A1 Method for increasing hydrophilicity of fluorescent label compounds |
| 01/16/2003 | WO2001074898A3 Charged compounds comprising a nucleic acid binding moiety and uses therefor |
| 01/02/2003 | EP1267904A2 Polypeptoid pulmonary surfactants |
| 12/31/2002 | US6500933 Methods of preparing carbohydrate crosslinked glycoprotein crystals |
| 12/25/2002 | CN1386745A Process for extracting thallus from waste liquid of gourmet powder |
| 12/18/2002 | EP1265921A1 Charged compounds comprising a nucleic acid binding moiety and uses therefor |
| 12/18/2002 | EP1265910A2 Nucleic acids, proteins, and antibodies |
| 12/11/2002 | EP1263944A2 Nucleic acids, proteins, and antibodies |
| 12/11/2002 | EP1263773A1 Oligonucleotide analogues, methods of synthesis and methods of use |
| 12/10/2002 | CA2080182C Nuclear inhibitor i-92 and its use for the production of a medicament |